Nanjing Bayi Hospital

Nanjing, Jiangsu 210002

0 studies enrolling now · 5 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Hepatocellular Carcinoma, Kidney Neoplasms, Well-differentiated Pancreatic Neuroendocrine Tumor

Studies at this site

• Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer — Completed
• A Study Of The Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors — Completed
• Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma — Completed
• An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene — Completed
• An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene — Completed